Back to search results

Sleep Restriction Therapy for Sleep Problems in Children With Autism

This study is testing a behavioral treatment called Sleep Restriction Therapy (SRT) for sleep problems in children with autism spectrum disorder (ASD). SRT involves therapist-led sessions where parents are trained to deliver the intervention. The study aims to see how acceptable, tolerable, and practical SRT is for children aged 6 to 12 years old who have been diagnosed with ASD and experience sleep disturbances. Researchers will measure these aspects at the end of the 10-week treatment period. The study is currently open, but its exact status is unclear, and it plans to enroll 25 participants.

Study design
This is an open-label study, meaning everyone knows what treatment is being given. It plans to enroll 25 participants.
What's involved
You would participate in therapist-led Sleep Restriction Therapy sessions delivered through a secure online platform. Parents will be trained to deliver the intervention.
Compensation
Not stated in the trial record.
Follow-up
The main measures of success are taken at the end of treatment, which is around week 10.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06627205

Sleep Restriction Therapy (SRT) for Sleep Problems in Children With Autism

Recruiting
NAAges 6–12InterventionalTreatment
Stanford University
~25 participants
Updated 2025-05-16 on ClinicalTrials.gov
What's tested:Sleep Restriction Therapy

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Acceptability of Sleep Restriction Therapy
Measured over At end of treatment (approximately week 10)
+2 more outcomes measured

Conditions

Autism Spectrum Disorder (ASD)
Autism

Explore related trials

Autism Spectrum DisorderSleep Disorder

Where it's being run

1 sites across 1 states
California1

Study leadership

  • Emma K Baker, MPsych(Clin), PhD · PRINCIPAL_INVESTIGATOR · Stanford University

Who to contact

Emma K Baker, MPsych(Clin), PhD
[email protected]
6507361235
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

diagnosed with autism spectrum disorder (based on history, review of available medical records including diagnostic testing, e.g., Autism Diagnostic Observation Schedule and/or Autism Diagnostic Interview-Revised, Childhood Autism Rating Scale-2)
with sleep disturbances (based on clinical interview, and Sleep Disturbance Scale for Children score \> 38)
stable pre-existing medication plans for at least 2 weeks
no planned changes in psychosocial and biomedical interventions during the intervention
an English-speaking parent able to consistently participate in study procedures
reside in California, USA

Exclusion

parent or child diagnosed with severe psychiatric disorder or unstable medical problem
children with active seizures or epilepsy
primary sleep disorder is a circadian rhythm sleep-wake disorder, as determined by the sleep interview and Children's ChronoType Questionnaire.
current active trial of sleep restriction therapy or history of an adequate trial of sleep restriction therapy.

What this trial measures

  • Acceptability of Sleep Restriction TherapyAt end of treatment (approximately week 10)

    Acceptability will be assessed using a series of questions rated by participants on a 5-point Likert scale (1-5) with 1 being the least acceptable and 5 being the most acceptable.

  • Tolerability of Sleep Restriction TherapyAt end of treatment (approximately week 10)

    Tolerability will be assessed using a series of questions rated by participants on a 5-point Likert scale (1-5) with 1 being the least tolerable and 5 being the most tolerable.

  • Feasibility of Sleep Restriction TherapyAt end of treatment (approximately week 10)

    Feasibility will be assessed using a series of questions rated by participants on a 5-point Likert scale (1-5) with 1 being the least feasible and 5 being the most feasible.